Oral administration of repurposed drug targeting Cyp46A1 increases survival times of prion infected mice
Abstract Prion diseases are fatal, infectious, and incurable neurodegenerative disorders caused by misfolding of the cellular prion protein (PrPC) into the infectious isoform (PrPSc). In humans, there are sporadic, genetic and infectious etiologies, with sporadic Creutzfeldt-Jakob disease (sCJD) bei...
Main Authors: | Tahir Ali, Samia Hannaoui, Satish Nemani, Waqas Tahir, Irina Zemlyankina, Pearl Cherry, Su Yeon Shim, Valerie Sim, Hermann M. Schaetzl, Sabine Gilch |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-04-01
|
Series: | Acta Neuropathologica Communications |
Online Access: | https://doi.org/10.1186/s40478-021-01162-1 |
Similar Items
-
Chronic wasting disease: Emerging prions and their potential risk.
by: Samia Hannaoui, et al.
Published: (2017-11-01) -
The Role of Vesicle Trafficking Defects in the Pathogenesis of Prion and Prion-Like Disorders
by: Pearl Cherry, et al.
Published: (2020-09-01) -
Cervid Prion Protein Polymorphisms: Role in Chronic Wasting Disease Pathogenesis
by: Maria Immaculata Arifin, et al.
Published: (2021-02-01) -
Propagation of PrPSc in mice reveals impact of aggregate composition on prion disease pathogenesis
by: Sheng Chun Chang, et al.
Published: (2023-11-01) -
Peptide aptamer-mediated modulation of prion protein α-cleavage as treatment strategy for prion and other neurodegenerative diseases
by: Antonia N Klein, et al.
Published: (2018-01-01)